\
&
Contact us
\
&
Contact us
Published on | 2 months ago
Programmes HealthThe European Partnership ofor Personalised Medicine (EP PerMed) is about to launch an international call titled 'Personalised Medicine for cardiovascular, metabolic, and kidney diseases' (CARMEN2026) to fund multinational, innovative research projects in personalised medicine.
The aim of this Call, foreseen to be launched on 25 November 2025, is to fund research projects in human health on innovative personalised medicine strategies for patients with cardiovascular, metabolic or kidney diseases. Research projects may focus on a single disease or explore these conditions in combination.
Proposals should address one or more of the following aspects:
Research Foundation Flanders (FWO) plans to participate in this call. More information on available funding for researchers based in Flanders and on how to apply is available on the FWO website. Deadline for the submission of pre-proposals is 10 February 2026. Questions on available funding by FWO? Contact europe@fwo.be.
More information on the call, its conditions and how to apply will be made available soon on the EP PerMed dedicated webpage. Interested in applying? Join the information webinar on 16 December 2025 here.
We offer news and event updates, covering all domains and topics of Horizon Europe, Digital Europe & EDF (and occasionally, for ongoing projects, Horizon 2020).
Stay informed about what matters to you.
By signing up, you can opt in for e-mail notifications and get access to
a personalised dashboard that groups all news updates and event announcements in your domain(s).
Only for stakeholders located in Flanders
Professor Inez Germeys leads the Center for Contextual Psychiatry at KU Leuven, which is a large multi-disciplinary research group focusing on the interaction between the person and the environment in the development of psychopathology. She has received a European Research Council (ERC) Consolidator grant (INTERACT) and Proof of Concept grant (IMPACT). With these grants professor Germeys and her team researched a new mobile self-management therapy for patients with a psychotic disorder. The Acceptance and Commitment Therapy in Daily Life (ACT-DL) was further developed for the clinical environment. In line with that the Horizon 2020 IMMERSE project aims to thoroughly evaluate strategies, processes, and outcomes of implementing a digital mobile mental health solution.
